RNVU1-19
gene geneOn this page
Also known as vU1.19RNU1-126vU1.13RNU1-147
Summary
RNVU1-19 (RNA, variant U1 small nuclear 19, HGNC:48324) is a small nuclear RNA gene on chromosome 1q21.2.
Predicted to enable pre-mRNA 5’-splice site binding activity. Predicted to be involved in mRNA 5’-splice site recognition. Predicted to be part of U1 snRNP.
Source: NCBI Gene 101954277 — RefSeq curated summary.
At a glance
- Gene type: non-coding (snRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:48324 |
| Approved symbol | RNVU1-19 |
| Name | RNA, variant U1 small nuclear 19 |
| Location | 1q21.2 |
| Locus type | RNA, small nuclear |
| Status | Approved |
| Aliases | vU1.19, RNU1-126, vU1.13, RNU1-147 |
| Ensembl gene | ENSG00000275538 |
| Ensembl biotype | snRNA |
| Entrez | 101954277 |
| RNAcentral | URS000075AD80 — snRNA, 167 nt, 2 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 snRNA
ENST00000613023
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000613023 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003719321 | 120850819 | 120850985 |
Expression profiles
Bgee: expression breadth broad, 92 present calls, max score 92.72.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 23.0081 / max 1051.0316, expressed in 1534 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 14108 | 23.0081 | 1534 |
Top tissues by expression
92 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 92.72 | gold quality |
| cortical plate | UBERON:0005343 | 91.52 | gold quality |
| liver | UBERON:0002107 | 81.93 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 80.35 | gold quality |
| adrenal tissue | UBERON:0018303 | 78.03 | gold quality |
| lymph node | UBERON:0000029 | 76.63 | gold quality |
| calcaneal tendon | UBERON:0003701 | 74.26 | gold quality |
| primary visual cortex | UBERON:0002436 | 72.81 | gold quality |
| kidney | UBERON:0002113 | 72.73 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 71.48 | gold quality |
| muscle of leg | UBERON:0001383 | 69.77 | gold quality |
| lung | UBERON:0002048 | 69.50 | gold quality |
| stomach | UBERON:0000945 | 69.25 | gold quality |
| monocyte | CL:0000576 | 67.83 | gold quality |
| islet of Langerhans | UBERON:0000006 | 67.32 | gold quality |
| blood | UBERON:0000178 | 66.89 | gold quality |
| heart | UBERON:0000948 | 66.71 | gold quality |
| bone marrow | UBERON:0002371 | 66.18 | gold quality |
| adrenal gland | UBERON:0002369 | 65.67 | gold quality |
| gastrocnemius | UBERON:0001388 | 65.39 | gold quality |
| right ovary | UBERON:0002118 | 64.98 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 64.47 | gold quality |
| body of pancreas | UBERON:0001150 | 61.76 | gold quality |
| vermiform appendix | UBERON:0001154 | 61.43 | gold quality |
| heart left ventricle | UBERON:0002084 | 61.25 | gold quality |
| tibial artery | UBERON:0007610 | 61.06 | gold quality |
| left coronary artery | UBERON:0001626 | 60.96 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 59.80 | gold quality |
| thoracic aorta | UBERON:0001515 | 59.66 | gold quality |
| prostate gland | UBERON:0002367 | 59.59 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.12 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (147): RNU1-75P (ENSG00000194297), RNU1-15P (ENSG00000195024), RNU1-58P (ENSG00000199283), RNU1-150P (ENSG00000199361), RNU1-108P (ENSG00000199426), RNU1-62P (ENSG00000199469), RNU1-70P (ENSG00000199488), RNU1-94P (ENSG00000199497), RNU1-14P (ENSG00000199629), RNU1-35P (ENSG00000199652), RNU1-38P (ENSG00000199687), RNU1-76P (ENSG00000199773), RNU1-134P (ENSG00000199805), RNU1-47P (ENSG00000199836), RNU1-72P (ENSG00000199846), RNVU1-22 (ENSG00000199879), RNU1-17P (ENSG00000199892), RNU1-18P (ENSG00000199932), RNU1-19P (ENSG00000200176), RNU1-20P (ENSG00000200184), RNU1-21P (ENSG00000200197), RNU1-22P (ENSG00000200204), RNU1-23P (ENSG00000200231), RNU1-83P (ENSG00000200296), RNU1-49P (ENSG00000200338), RNU1-105P (ENSG00000200340), RNVU1-33 (ENSG00000200597), RNU1-124P (ENSG00000200731), RNU1-31P (ENSG00000200745), RNU1-65P (ENSG00000200789), RNU1-130P (ENSG00000200800), RNU1-32P (ENSG00000200807), RNU1-146P (ENSG00000200885), RNU1-42P (ENSG00000200903), RNU1-7P (ENSG00000200975), RNVU1-34 (ENSG00000200997), RNU1-96P (ENSG00000201033), RNU1-33P (ENSG00000201119), RNU1-151P (ENSG00000201142), RNU1-24P (ENSG00000201155)
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.